Drug Type Vaccine |
Synonyms- |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza, Human | Phase 1 | US | 10 Oct 2017 | |
Influenza, Human | Phase 1 | US | 10 Oct 2017 |
Phase 1 | 65 | (Group 1: cH8/1N1 LAIV and cH5/1N1 IIV + Adjuvant) | gouyouznim(ommwsbwvwy) = yegmwzegqc tzqdlhrplz (nrklwnwujo, vlxjyrzcbr - xnyubsawfe) View more | - | 21 Feb 2021 | ||
cH5/1N1 IIV+cH8/1N1 LAIV (Group 2: cH8/1N1 LAIV and cH5/1N1 IIV) | gouyouznim(ommwsbwvwy) = pjdibevdwz tzqdlhrplz (nrklwnwujo, lezyvyjzzn - ecokgdguim) View more |